Skip to main content
Equibles

RAJAF · TFA Therapeutics, Inc.

Track RAJAF — free

Use RAJAF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$9.18 At close · Jul 9
Rebalance outlook locked
Market Cap
$1.02B
Shares
111.12M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$9.18 Open$9.18 Day$9.18–10.56 52W close$0.04–9.22 Avg vol available · 27d1K Short int61 · 0.0% float · 1.8d Short vol30% DataJul 2024–Jul 2025

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Bearish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
RSI (14) 79
overbought
52-week position 100%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +206%
trailing
YTD return +11%
this year
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
Revenue growth −1%
Y/Y
Gross margin 61%
contracting
Free cash flow $-385.1K
Quant / Vol
risk profile
Very High
Volatility 1361%
annualized · 1-yr
Max drawdown −19%
past year
ATR 6.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 2 · 1
50 / 200-day cross
No cross Neutral
RSI (14)
79 Bearish
52-week position
100% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $9 · 100% Range high $9

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RAJAF
TFA Therapeutics, Inc.
this stock
$1.02B — -0.6% — 0.0%
KHC
Kraft Heinz Co
 $29.47B +2.5% -0.1% — 7.2%
GIS
General Mills Inc
 $20.44B -17.7% +4.1% — 8.4%
MKC
Mccormick & Co Inc
 $14.00B -23.5% +1.7% 8.7 4.9%
JBS
Jbs N.V.
 $13.95B -9.6% — — 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
61
Days to cover
1.8d
Change
+61 sh
View
Short Volume
Short vol %
30%
As of
Oct 16, 2025
Short Total
View
Fails to Deliver
FTD shares
61
Value
$184
As of
Nov 7, 2025
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 7, 2025
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.2M
Net income (FY)
$-154.8K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 2, 2026
This year
4
View

Performance

5D 20D 120D MTD YTD
RAJAF +1.1% +206.0% — +7.2% +11.3%
SPY +1.0% +4.1% +7.2% +1.0% +6.5%
vs SPY +0.1% +201.9% — +6.2% +4.8%
Key facts CIK 1885680 Visit website